Stay up to date with the latest developments. 

Read about this ongoing multi-center prospective study (ClinicalTrials.gov NCT03984747) designed to improve Natera’s method for determining allograft rejection status in Kidney transplant recipients by using donor-derived cell-free DNA analysis with the Prospera Transplant Assessment test. 

View publications, brochures, and presentations.